239 related articles for article (PubMed ID: 20068069)
21. CCDC22 deficiency in humans blunts activation of proinflammatory NF-κB signaling.
Starokadomskyy P; Gluck N; Li H; Chen B; Wallis M; Maine GN; Mao X; Zaidi IW; Hein MY; McDonald FJ; Lenzner S; Zecha A; Ropers HH; Kuss AW; McGaughran J; Gecz J; Burstein E
J Clin Invest; 2013 May; 123(5):2244-56. PubMed ID: 23563313
[TBL] [Abstract][Full Text] [Related]
22. HMGB1 induction of clusterin creates a chemoresistant niche in human prostate tumor cells.
Zhou J; Chen X; Gilvary DL; Tejera MM; Eksioglu EA; Wei S; Djeu JY
Sci Rep; 2015 Oct; 5():15085. PubMed ID: 26469759
[TBL] [Abstract][Full Text] [Related]
23. Suppression of NF-kappaB and NF-kappaB-regulated gene expression by sulforaphane and PEITC through IkappaBalpha, IKK pathway in human prostate cancer PC-3 cells.
Xu C; Shen G; Chen C; Gélinas C; Kong AN
Oncogene; 2005 Jun; 24(28):4486-95. PubMed ID: 15856023
[TBL] [Abstract][Full Text] [Related]
24. The ubiquitin-proteasome pathway and enhanced activity of NF-kappaB in gastric carcinoma.
Wu L; Pu Z; Feng J; Li G; Zheng Z; Shen W
J Surg Oncol; 2008 Apr; 97(5):439-44. PubMed ID: 18163448
[TBL] [Abstract][Full Text] [Related]
25. Clusterin, a Novel DEC1 Target, Modulates DNA Damage-Mediated Cell Death.
Ming X; Bao C; Hong T; Yang Y; Chen X; Jung YS; Qian Y
Mol Cancer Res; 2018 Nov; 16(11):1641-1651. PubMed ID: 30002194
[TBL] [Abstract][Full Text] [Related]
26. The human immunodeficiency virus type 1 Vpu protein inhibits NF-kappa B activation by interfering with beta TrCP-mediated degradation of Ikappa B.
Bour S; Perrin C; Akari H; Strebel K
J Biol Chem; 2001 May; 276(19):15920-8. PubMed ID: 11278695
[TBL] [Abstract][Full Text] [Related]
27. Clusterin over-expression modulates proapoptotic and antiproliferative effects of 1,25(OH)2D3 in prostate cancer cells in vitro.
Shannan B; Seifert M; Boothman DA; Tilgen W; Reichrath J
J Steroid Biochem Mol Biol; 2007 Mar; 103(3-5):721-5. PubMed ID: 17224269
[TBL] [Abstract][Full Text] [Related]
28. RNA interference-mediated secretory clusterin gene silencing inhibits proliferation and promotes apoptosis of human non-small cell lung cancer cells.
Yan Y; Luo K; Zhang H; Chai W
Hepatogastroenterology; 2013; 60(121):70-5. PubMed ID: 22975582
[TBL] [Abstract][Full Text] [Related]
29. Clusterin isoforms differentially affect growth and motility of prostate cells: possible implications in prostate tumorigenesis.
Moretti RM; Montagnani Marelli M; Mai S; Cariboni A; Scaltriti M; Bettuzzi S; Limonta P
Cancer Res; 2007 Nov; 67(21):10325-33. PubMed ID: 17974975
[TBL] [Abstract][Full Text] [Related]
30. TAGLN Is Downregulated by TRAF6-Mediated Proteasomal Degradation in Prostate Cancer Cells.
Wen F; Sun X; Sun C; Dong Z; Jia G; Bao W; Yu H; Yang C
Mol Cancer Res; 2021 Jul; 19(7):1113-1122. PubMed ID: 33771884
[TBL] [Abstract][Full Text] [Related]
31. NF-kappaB regulates the stability and activity of p73 by inducing its proteolytic degradation through a ubiquitin-dependent proteasome pathway.
Kikuchi H; Ozaki T; Furuya K; Hanamoto T; Nakanishi M; Yamamoto H; Yoshida K; Todo S; Nakagawara A
Oncogene; 2006 Dec; 25(58):7608-17. PubMed ID: 16953234
[TBL] [Abstract][Full Text] [Related]
32. IkappaB/NF-kappaB mediated cisplatin resistance in HeLa cells after low-dose gamma-irradiation is associated with altered SODD expression.
Eichholtz-Wirth H; Sagan D
Apoptosis; 2000 Jun; 5(3):255-63. PubMed ID: 11225847
[TBL] [Abstract][Full Text] [Related]
33. COMMD1 Promotes pVHL and O2-Independent Proteolysis of HIF-1alpha via HSP90/70.
van de Sluis B; Groot AJ; Vermeulen J; van der Wall E; van Diest PJ; Wijmenga C; Klomp LW; Vooijs M
PLoS One; 2009 Oct; 4(10):e7332. PubMed ID: 19802386
[TBL] [Abstract][Full Text] [Related]
34. Small interfering RNA targeted to secretory clusterin blocks tumor growth, motility, and invasion in breast cancer.
Niu Z; Li X; Hu B; Li R; Wang L; Wu L; Wang X
Acta Biochim Biophys Sin (Shanghai); 2012 Dec; 44(12):991-8. PubMed ID: 23099883
[TBL] [Abstract][Full Text] [Related]
35. Enhanced heat shock protein 70 expression alters proteasomal degradation of IkappaB kinase in experimental acute respiratory distress syndrome.
Weiss YG; Bromberg Z; Raj N; Raphael J; Goloubinoff P; Ben-Neriah Y; Deutschman CS
Crit Care Med; 2007 Sep; 35(9):2128-38. PubMed ID: 17855826
[TBL] [Abstract][Full Text] [Related]
36. Repression of IR-inducible clusterin expression by the p53 tumor suppressor protein.
Criswell T; Klokov D; Beman M; Lavik JP; Boothman DA
Cancer Biol Ther; 2003; 2(4):372-80. PubMed ID: 14508108
[TBL] [Abstract][Full Text] [Related]
37. Age-related decrease in proteasome expression contributes to defective nuclear factor-kappaB activation during hepatic ischemia/reperfusion.
Huber N; Sakai N; Eismann T; Shin T; Kuboki S; Blanchard J; Schuster R; Edwards MJ; Wong HR; Lentsch AB
Hepatology; 2009 May; 49(5):1718-28. PubMed ID: 19206148
[TBL] [Abstract][Full Text] [Related]
38. Ubiquitin ligase CHIP induces TRAF2 proteasomal degradation and NF-κB inactivation to regulate breast cancer cell invasion.
Jang KW; Lee KH; Kim SH; Jin T; Choi EY; Jeon HJ; Kim E; Han YS; Chung JH
J Cell Biochem; 2011 Dec; 112(12):3612-20. PubMed ID: 21793045
[TBL] [Abstract][Full Text] [Related]
39. Cellular inhibitors of apoptosis are global regulators of NF-κB and MAPK activation by members of the TNF family of receptors.
Varfolomeev E; Goncharov T; Maecker H; Zobel K; Kömüves LG; Deshayes K; Vucic D
Sci Signal; 2012 Mar; 5(216):ra22. PubMed ID: 22434933
[TBL] [Abstract][Full Text] [Related]
40. HSP27 is a ubiquitin-binding protein involved in I-kappaBalpha proteasomal degradation.
Parcellier A; Schmitt E; Gurbuxani S; Seigneurin-Berny D; Pance A; Chantôme A; Plenchette S; Khochbin S; Solary E; Garrido C
Mol Cell Biol; 2003 Aug; 23(16):5790-802. PubMed ID: 12897149
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
